The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Heron Therapeutics Inc (HRTX), where a total volume of 8,167 contracts has been traded thus far today, a contract volume which is representative of approximately 816,700 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 86.4% of HRTX's average daily trading volume over the past month, of 945,110 shares..
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
PQ Group (PQG) delivered earnings and revenue surprises of -23.08% and -0.01%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?